In contrast, promotion of ADAM10 activity on neurons could alleviate Alzheimer disease by preventing the generation of pathogenic β-amyloid peptides (1), and on platelets could prevent heart attack and stroke caused by thrombosis, through collagen receptor GPVI shedding (4, 5). Here, GP6 is linked to early-onset autosomal dominant Alzheimer disease.